View in EDS PDF Full Text

Report of the AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Japan Pharmaceutical Manufacturers Association: an overview of recent publications about AI pathology.

Saved in:
Bibliographic Details
Title: Report of the AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Japan Pharmaceutical Manufacturers Association: an overview of recent publications about AI pathology.
Authors: Tomikawa E; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Toray Industries, Inc., 6-10-1 Tebiro, Kamakura-shi, Kanagawa 248-8555, Japan., Sakai S; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni, Shizuoka 410-2321, Japan., Yamagiwa Y; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Senju Pharmaceutical Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan., Kangawa Y; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Nippon Boehringer Ingelheim Co., Ltd., 6-7-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan., Kagawa Y; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Novartis Pharma K.K., 1-23-1 Toranomon, Minato-ku, Tokyo 105-6333, Japan., Kato Y; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Shionogi & Co., Ltd., 3-3-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan., Kojima K; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Kyowa Kirin Co., Ltd., 1188 Shimotogari, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8731, Japan., Inomata A; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; FUJIFILM Toyama Chemical Co., Ltd., 4-1 Shimookui 2-chome, Toyama 930-8508, Japan., Matsumoto I; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Sumitomo Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan., Sato G; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Sumitomo Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan., Suzuki M; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Kyowa Kirin Co., Ltd., 1188 Shimotogari, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8731, Japan.
Source: Journal of toxicologic pathology [J Toxicol Pathol] 2025 Jul; Vol. 38 (3), pp. 191-198. Date of Electronic Publication: 2025 Mar 11.
Publication Type: Journal Article; Review
Journal Info: Publisher: Japanese Society of Toxicologic Pathology Country of Publication: Japan NLM ID: 9306408 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0914-9198 (Print) Linking ISSN: 09149198 NLM ISO Abbreviation: J Toxicol Pathol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40606550
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Report of the AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Japan Pharmaceutical Manufacturers Association: an overview of recent publications about AI pathology.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tomikawa+E%22">Tomikawa E</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Toray Industries, Inc., 6-10-1 Tebiro, Kamakura-shi, Kanagawa 248-8555, Japan.<br /><searchLink fieldCode="AU" term="%22Sakai+S%22">Sakai S</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni, Shizuoka 410-2321, Japan.<br /><searchLink fieldCode="AU" term="%22Yamagiwa+Y%22">Yamagiwa Y</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Senju Pharmaceutical Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.<br /><searchLink fieldCode="AU" term="%22Kangawa+Y%22">Kangawa Y</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Nippon Boehringer Ingelheim Co., Ltd., 6-7-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.<br /><searchLink fieldCode="AU" term="%22Kagawa+Y%22">Kagawa Y</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Novartis Pharma K.K., 1-23-1 Toranomon, Minato-ku, Tokyo 105-6333, Japan.<br /><searchLink fieldCode="AU" term="%22Kato+Y%22">Kato Y</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Shionogi & Co., Ltd., 3-3-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Kojima+K%22">Kojima K</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Kyowa Kirin Co., Ltd., 1188 Shimotogari, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8731, Japan.<br /><searchLink fieldCode="AU" term="%22Inomata+A%22">Inomata A</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; FUJIFILM Toyama Chemical Co., Ltd., 4-1 Shimookui 2-chome, Toyama 930-8508, Japan.<br /><searchLink fieldCode="AU" term="%22Matsumoto+I%22">Matsumoto I</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Sumitomo Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+G%22">Sato G</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Sumitomo Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+M%22">Suzuki M</searchLink>; AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceuticals Manufacturers Association, 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023, Japan.; Kyowa Kirin Co., Ltd., 1188 Shimotogari, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8731, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229306408%22">Journal of toxicologic pathology</searchLink> [J Toxicol Pathol] 2025 Jul; Vol. 38 (3), pp. 191-198. <i>Date of Electronic Publication: </i>2025 Mar 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Japanese+Society+of+Toxicologic+Pathology%22">Japanese Society of Toxicologic Pathology </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9306408 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0914-9198 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209149198%22">09149198 </searchLink><i>NLM ISO Abbreviation: </i>J Toxicol Pathol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40606550
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1293/tox.2024-0100
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 191
    Titles:
      – TitleFull: Report of the AI Pathology Task Force, Non-clinical Evaluation Expert Committee, Japan Pharmaceutical Manufacturers Association: an overview of recent publications about AI pathology.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tomikawa E
      – PersonEntity:
          Name:
            NameFull: Sakai S
      – PersonEntity:
          Name:
            NameFull: Yamagiwa Y
      – PersonEntity:
          Name:
            NameFull: Kangawa Y
      – PersonEntity:
          Name:
            NameFull: Kagawa Y
      – PersonEntity:
          Name:
            NameFull: Kato Y
      – PersonEntity:
          Name:
            NameFull: Kojima K
      – PersonEntity:
          Name:
            NameFull: Inomata A
      – PersonEntity:
          Name:
            NameFull: Matsumoto I
      – PersonEntity:
          Name:
            NameFull: Sato G
      – PersonEntity:
          Name:
            NameFull: Suzuki M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 0914-9198
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of toxicologic pathology
              Type: main
ResultId 1